Paloma Partners’s Compugen CGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEN
AIM
NAMA
RSCM
TFCM
Paloma Partners's CGEN Position: Q2 2022 in Review
Paloma Partners sold out of Compugen (CGEN) in Q2 2022, closing a stake of 67,351 shares — an estimated $217K sold.
Paloma Partners first reported a position in CGEN in Q4 2017 and held it in 6 quarters. The position peaked at $666K in Q1 2021. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.
- Paloma Partners reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
- Paloma Partners sold 67,351 Compugen shares in Q2 2022, an estimated $217K.
- Paloma Partners first reported a position in Compugen in Q4 2017 and held it in 6 quarters.
- Paloma Partners's Compugen position peaked at $666K in Q1 2021.
- 89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.
Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.